Jennison Associates’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-6,977
| Closed | -$418K | – | 746 |
|
2019
Q4 | $418K | Sell |
6,977
-577,416
| -99% | -$34.6M | ﹤0.01% | 599 |
|
2019
Q3 | $16.4M | Sell |
584,393
-30,985
| -5% | -$870K | 0.02% | 338 |
|
2019
Q2 | $23.3M | Sell |
615,378
-731,592
| -54% | -$27.7M | 0.02% | 322 |
|
2019
Q1 | $52.6M | Buy |
1,346,970
+322,279
| +31% | +$12.6M | 0.05% | 214 |
|
2018
Q4 | $21.8M | Sell |
1,024,691
-3,977
| -0.4% | -$84.8K | 0.02% | 340 |
|
2018
Q3 | $40.7M | Buy |
1,028,668
+8,112
| +0.8% | +$321K | 0.04% | 280 |
|
2018
Q2 | $39M | Buy |
1,020,556
+17,877
| +2% | +$683K | 0.04% | 299 |
|
2018
Q1 | $30.1M | Buy |
1,002,679
+148,857
| +17% | +$4.47M | 0.03% | 337 |
|
2017
Q4 | $26.7M | Buy |
853,822
+9,762
| +1% | +$305K | 0.03% | 359 |
|
2017
Q3 | $23.6M | Sell |
844,060
-2,213
| -0.3% | -$62K | 0.02% | 381 |
|
2017
Q2 | $16.2M | Buy |
846,273
+546,617
| +182% | +$10.5M | 0.02% | 428 |
|
2017
Q1 | $5.11M | Hold |
299,656
| – | – | 0.01% | 506 |
|
2016
Q4 | $5.48M | Buy |
299,656
+1,070
| +0.4% | +$19.6K | 0.01% | 502 |
|
2016
Q3 | $5.32M | Buy |
+298,586
| New | +$5.32M | 0.01% | 503 |
|